Connective tissue and epithelial tissue differ in the spacing of cells. The cells are closer together in connective tissue than in epithelial tissue. In contrast, epithelial tissue has large spaces containing extracellular matrix, while there are no cells in connective tissue. There is more space between cells in connective tissue than in epithelial tissue, where the cells are tightly packed. Therefore, the spacing of cells in connective tissue varies from the spacing in epithelial tissue. The extracellular matrix in epithelial tissue plays an important role in cell growth, cell differentiation, and other cellular processes.
The spacing of cells in connective tissue is different from that in epithelial tissue. The cells are closer together in connective tissue than in epithelial tissue. In contrast, epithelial tissue has large spaces containing extracellular matrix, while there are no cells in connective tissue. There is more space between cells in connective tissue than in epithelial tissue, where the cells are tightly packed. Therefore, the spacing of cells in connective tissue varies from the spacing in epithelial tissue. The extracellular matrix in epithelial tissue plays an important role in cell growth, cell differentiation, and other cellular processes.
The spacing of cells in connective tissue is different from that in epithelial tissue. Epithelial tissue has large spaces containing extracellular matrix, while there are no cells in connective tissue. The cells are closer together in connective tissue than in epithelial tissue. Therefore, the spacing of cells in connective tissue varies from the spacing in epithelial tissue. The extracellular matrix in epithelial tissue plays an important role in cell growth, cell differentiation, and other cellular processes.
To know more about epithelial tissue visit:
https://brainly.com/question/29361246
#SPJ11
Which clinical indicators should the nurse monitor when a patient takes a cholinesterase inhibitor?
1
Urinary retention
2
Increased heart rate
3
Decreased gastric secretion
4
Increased bronchial secretion
If taking a cholinesterase inhibitor like echothiophate iodide, an ophthalmic medication used in the treatment of patients with high intraocular pressure or children who are cross-eyed, the nurse should monitor the patient for tachycardia or, option 2, an increased heart rate. This may be indicative that the patient is experiencing an adverse reaction to the medication and the pharmacological therapy may need to be changed and or discontinued.
The clinical indicators that the nurse should monitor when a patient takes a cholinesterase inhibitor include urinary retention, bradycardia, increased bronchial secretion, and gastrointestinal distress.
Cholinesterase inhibitors are medications used to increase the concentration of acetylcholine in the brain. They function by stopping the activity of the cholinesterase enzyme, which is responsible for degrading acetylcholine. Acetylcholine is responsible for transmitting nerve impulses in the brain, so cholinesterase inhibitors are prescribed to treat conditions characterized by a shortage of acetylcholine. The nurse must monitor the patient for adverse effects of cholinesterase inhibitors. The clinical indicators that the nurse should monitor when a patient takes a cholinesterase inhibitor include urinary retention, bradycardia, increased bronchial secretion, and gastrointestinal distress. These adverse effects are mostly due to the inhibition of acetylcholinesterase by the medication.
In conclusion, the nurse must monitor the patient for urinary retention, bradycardia, increased bronchial secretion, and gastrointestinal distress when a patient takes a cholinesterase inhibitor.
To know more about Cholinesterase inhibitors, visit:
https://brainly.com/question/30584429
#SPJ11